C4 Therapeutics director exercises 1,070 stock options
C4 Therapeutics director Kenneth Carl Anderson exercised stock options to acquire 1,070 shares of common stock on June 1, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
C4 Therapeutics director Kenneth Carl Anderson exercised stock options to acquire 1,070 shares of common stock on June 1, 2026. The options were exercised at a price of $2.11 per share for cash, and no shares were sold in connection with the exercise.
Following the exercise, Anderson directly holds 69,300 shares of C4 Therapeutics common stock. Additional shares are held indirectly through several revocable and irrevocable trusts associated with Anderson and Cynthia E. Anderson, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,070 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,070 | $2.11 | $2K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (7)
- F1. The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise.
- F2. Shares held by the Kenneth C. Anderson 2021 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F3. Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F4. Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F5. Shares held by the Kenneth C. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F6. Shares held by the Cynthia E. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F7. The shares underlying this option are fully vested and exercisable.
Key Figures
Key Terms
stock option financial
derivative security financial
revocable trust financial
irrevocable trust financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did C4 Therapeutics (CCCC) report for Kenneth Carl Anderson?
At what price did Kenneth Carl Anderson exercise C4 Therapeutics (CCCC) stock options?
Were all stock options underlying this C4 Therapeutics (CCCC) grant fully vested?
AI-generated analysis. How Rhea-AI works. Not financial advice.